tradingkey.logo
tradingkey.logo
Search

RINVOQ (upadacitinib) Receives U.S. FDA Approval for Giant Cell Arteritis (GCA)

ReutersApr 29, 2025 12:26 PM
facebooktwitterlinkedin

- Abbvie Inc ABBV.N:

  • RINVOQ® (UPADACITINIB) RECEIVES U.S. FDA APPROVAL FOR GIANT CELL ARTERITIS (GCA)

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Recommended Articles

Tradingkey
KeyAI